TNF Pharmaceuticals, Inc. SC 13G and SC 13G/A reports

Location
855 N. Wolfe Street, Suite 601, Baltimore, MD
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/14/2024, 05:03 PM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report SC 13G/A Nov 14, 2024
SC 13G Report ANNUAL SC 13G - POTX/MYMD PHARMACEUTICALS Feb 14, 2024
SC 13G/A Report Feb 14, 2024
SC 13G/A Report Feb 14, 2023
SC 13G/A Report Feb 23, 2022
SC 13G/A Report AMENDMENT NO. 2 TO SCHEDULE 13G Feb 11, 2022
SC 13G/A Report SC 13G/A Jan 11, 2022
SC 13G/A Report Feb 22, 2021
SC 13G Report SC 13G Feb 18, 2021
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Jan 29, 2021
SC 13G Report SCHEDULE 13G Nov 20, 2020
SC 13G/A Report Nov 19, 2020
SC 13G Report SCHEDULE 13G May 26, 2020
SC 13G/A Report AKER 13GA May 5, 2020
SC 13G/A Report AMENDMENT NO. 3 TO SCHEDULE 13G Apr 20, 2020
SC 13G Report SCHEDULE 13G Apr 17, 2020
SC 13G Report AKER_13G Jan 9, 2020
SC 13G Report SCHEDULE 13G Dec 19, 2019
SC 13G Report Dec 18, 2019
SC 13G Report Dec 13, 2019
SC 13G/A Report AMENDMENT NO.2 TO SCHEDULE 13G Dec 11, 2019
SC 13G/A Report AKER 13GA Jan 30, 2019
SC 13G/A Report AKERS BIOSCIENCES, INC. Jan 10, 2019
SC 13G/A Report AMENDMENT NO. 1 TO SCHEDULE 13G Jul 26, 2018
SC 13G/A Report May 7, 2018
SC 13G/A Report AMENDMENT NO. 1 TO THE SCHEDULE 13G Feb 13, 2018
SC 13G Report AKERS BIOSCIENCES, INC. Feb 1, 2018
SC 13G/A Report EMPERY ASSET MANAGEMENT, LP Jan 18, 2018
SC 13G Report THE SCHEDULE 13G Jan 2, 2018
SC 13G Report SCHEDULE 13G Dec 22, 2017
SC 13G Report AKERS BIOSCIENCES INC Apr 7, 2017
SC 13G/A Report SC 13G/A Jan 25, 2016
SC 13G/A Report SC 13G/A Jan 23, 2015
SC 13G Report SC 13G Feb 25, 2014